122 related articles for article (PubMed ID: 15979323)
1. Immunosuppression, IBD, and risk of lymphoma.
Bebb JR; Aithal GP; Logan RP
Gut; 2002 Aug; 51(2):296. PubMed ID: 12117900
[No Abstract] [Full Text] [Related]
2. Nonmelanoma skin cancer in inflammatory bowel disease: a review.
Long MD; Kappelman MD; Pipkin CA
Inflamm Bowel Dis; 2011 Jun; 17(6):1423-7. PubMed ID: 21053358
[TBL] [Abstract][Full Text] [Related]
3. The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?
Bourgonje AR; Otten AT
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1971-1972. PubMed ID: 36642294
[No Abstract] [Full Text] [Related]
4. The Metabolites of
Su L; Ma F; An Z; Ji X; Zhang P; Yue Q; Zhao C; Sun X; Li K; Li B; Liu X; Zhao L
Front Microbiol; 2022; 13():865925. PubMed ID: 35572623
[TBL] [Abstract][Full Text] [Related]
5. Diffuse large B-cell lymphoma of the rectum in a patient with Crohn's disease.
Hardy AJ; Stoica I; Kearney DE; O'Riordain DS
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32303524
[TBL] [Abstract][Full Text] [Related]
6. Looking for the best anti-colitis medicine: A comparative analysis of current and prospective compounds.
Chumanevich AA; Chaparala A; Witalison EE; Tashkandi H; Hofseth AB; Lane C; Pena E; Liu P; Pittman DL; Nagarkatti P; Nagarkatti M; Hofseth LJ; Chumanevich AA
Oncotarget; 2017 Jan; 8(1):228-237. PubMed ID: 27974688
[TBL] [Abstract][Full Text] [Related]
7. EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?
Allen PB; Laing G; Connolly A; O'Neill C
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24081592
[TBL] [Abstract][Full Text] [Related]
8. Mesentery lymphoma in a patient with Crohn's disease: An extremely rare entity.
Koronakis N; Lagoudianakis E; Keramidaris D; Pappas A; Gemenetzis G; Seretis C; Chrysikos J; Manouras A
Int J Surg Case Rep; 2012; 3(7):343-5. PubMed ID: 22580080
[TBL] [Abstract][Full Text] [Related]
9. Treating rheumatic patients with a malignancy.
Elandt K; Aletaha D
Arthritis Res Ther; 2011 Jun; 13(3):223. PubMed ID: 21722342
[TBL] [Abstract][Full Text] [Related]
10. [Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis].
Horneff G
Z Rheumatol; 2010 Aug; 69(6):516-26. PubMed ID: 20532787
[TBL] [Abstract][Full Text] [Related]
11. Dietary phenethylisothiocyanate attenuates bowel inflammation in mice.
Dey M; Kuhn P; Ribnicky D; Premkumar V; Reuhl K; Raskin I
BMC Chem Biol; 2010 Apr; 10():4. PubMed ID: 20423518
[TBL] [Abstract][Full Text] [Related]
12. [Updated statement by the German Society for Pediatric and Adolescent Rheumatology (GKJR) on the FDA's report regarding malignancies in anti-TNF-treated patients from Aug. 4, 2009].
Horneff G; Hospach T; Dannecker G; Föll D; Haas JP; Girschick HJ; Huppertz HI; Keitzer R; Laws HJ; Michels H; Minden K; Trauzeddel R
Z Rheumatol; 2010 Aug; 69(6):561-7. PubMed ID: 20174926
[TBL] [Abstract][Full Text] [Related]
13. Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?
Zhang Z; Rosenbaum JT; Zhong W; Lim C; Hinrichs DJ
Semin Immunopathol; 2010 Mar; 32(1):55-70. PubMed ID: 20119686
[TBL] [Abstract][Full Text] [Related]
14. Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review.
Dillon P; Thomas N; Sharpless N; Collichio F
Med Oncol; 2010 Dec; 27(4):1127-32. PubMed ID: 19890737
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
Kempen JH; Gangaputra S; Daniel E; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Helzlsouer KJ
Am J Ophthalmol; 2008 Dec; 146(6):802-12.e1. PubMed ID: 18579112
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report.
Cameron C; Greenbaum L; Sato T; Trost B; Lundeen B; Kelly ME
Pediatr Nephrol; 2008 Jul; 23(7):1167-70. PubMed ID: 18286306
[TBL] [Abstract][Full Text] [Related]
17. Atopic and non-atopic eczema.
Brown S; Reynolds NJ
BMJ; 2006 Mar; 332(7541):584-8. PubMed ID: 16528081
[No Abstract] [Full Text] [Related]
18. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
Kwon JH; Farrell RJ
Crit Rev Oncol Hematol; 2005 Oct; 56(1):169-78. PubMed ID: 15979323
[TBL] [Abstract][Full Text] [Related]
19. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
